Literature DB >> 2428697

Hypotony and experimental rubeosis iridis in primate eyes. A clinicopathologic study.

G A Peyman, M Raichand, C P Juarez, S Reinglass, E John.   

Abstract

Rubeosis iridis was produced in cynomolgus monkeys by subjecting their eyes to severe surgically induced hypotony. New vessels on the iris showed characteristic fenestrations of endothelial cell walls as well as mitotic activity.

Entities:  

Mesh：

Year:  1986        PMID： 2428697     DOI： 10.1007/bf02173359

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN： 0721-832X            Impact factor:   3.117


  24 in total

1.  Neovascularization in ocular disease.

Authors:  N ASHTON
Journal:  Trans Ophthalmol Soc U K       Date:  1961

2.  Retinal vascularization in health and disease: Proctor Award Lecture of the Association for Research in Ophthalmology.

Authors:  N ASHTON
Journal:  Am J Ophthalmol       Date:  1957-10       Impact factor: 5.258

3.  Central retinal vein thrombosis and hemorrhagic glaucoma.

Authors:  P BRAENDSTRUP
Journal:  Acta Ophthalmol Suppl       Date:  1950

Review 4.  Neovascularization of the iris (rubeosis iridis).

Authors:  S Gartner; P Henkind
Journal:  Surv Ophthalmol       Date:  1978 Mar-Apr       Impact factor: 6.048

5.  Neovascularization of the iris: an experimental model in cats.

Authors:  E Stefansson; M B Landers; M L Wolbarsht; G K Klintworth
Journal:  Invest Ophthalmol Vis Sci       Date:  1984-03       Impact factor: 4.799

6.  Four hundred consecutive pars plana vitrectomies with the vitrophage.

Authors:  G A Peyman; F U Huamonte; M F Goldberg; D R Sanders; K C Nagpal; M Raichand
Journal:  Arch Ophthalmol       Date:  1978-01

7.  Provoked iris ischaemia in the rabbit: A fluorescien angiographic study.

Authors:  M Kottow; P Wassilewa; P Hendrickson
Journal:  Can J Ophthalmol       Date:  1975-04       Impact factor: 1.882

8.  Experimental immunogenic rubeosis iridis.

Authors:  A L Shabo; D S Maxwell; P Shintaku; A E Kreiger; B R Straatsma
Journal:  Invest Ophthalmol Vis Sci       Date:  1977-04       Impact factor: 4.799

9.  Neovasculogenic ability of prostaglandins, growth factors, and synthetic chemoattractants.

Authors:  D BenEzra
Journal:  Am J Ophthalmol       Date:  1978-10       Impact factor: 5.258

10.  Hematoporphyrin photoradiation therapy for iris neovascularization. A preliminary report.

Authors:  A J Packer; D T Tse; X Q Gu; S S Hayreh
Journal:  Arch Ophthalmol       Date:  1984-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.